Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2016
DOI: 10.1016/j.bulcan.2016.02.002
|View full text |Cite
|
Sign up to set email alerts
|

Méthotrexate intrathécal dans les méningites carcinomateuses du cancer du sein – Expérience avec le protocole utilisé à l’hôpital Saint-Louis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

2
1
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 28 publications
2
1
0
Order By: Relevance
“…However, the symptoms at diagnosis can be very diverse in the case of very extensive meningeal involvement or diffuse peri-medullary leptomeningeal involvement. This is in agreement with the data of Cochereau et al, In a retrospective series of 41 patients followed up for carcinomatous leptomeningitis, they found that headache was indeed by far the most frequent symptom at diagnosis, but also that symptoms related to cranial pair involvement or medullary or radicular leptomeningeal involvement were also relevant and could be the sole indicators of Carcinomatous meningitis [7]. Thus, in current clinical practice, a meticulous neurological examination is essential and a hypothesis of Carcinomatous meningitis should systematically be evoked when neurological symptoms of all types (central or peripheral) appear in patients followed for cancers, and not only for cancers known to have the propensity to metastasise to the cerebral-meningeal level.…”
Section: © 2023: Global Academic Journal's Research Consortium (Gajrc...supporting
confidence: 92%
See 2 more Smart Citations
“…However, the symptoms at diagnosis can be very diverse in the case of very extensive meningeal involvement or diffuse peri-medullary leptomeningeal involvement. This is in agreement with the data of Cochereau et al, In a retrospective series of 41 patients followed up for carcinomatous leptomeningitis, they found that headache was indeed by far the most frequent symptom at diagnosis, but also that symptoms related to cranial pair involvement or medullary or radicular leptomeningeal involvement were also relevant and could be the sole indicators of Carcinomatous meningitis [7]. Thus, in current clinical practice, a meticulous neurological examination is essential and a hypothesis of Carcinomatous meningitis should systematically be evoked when neurological symptoms of all types (central or peripheral) appear in patients followed for cancers, and not only for cancers known to have the propensity to metastasise to the cerebral-meningeal level.…”
Section: © 2023: Global Academic Journal's Research Consortium (Gajrc...supporting
confidence: 92%
“…The prognosis for Carcinomatous meningitis is generally poor with survival rarely exceeding 4 months. In their series of 41 patients who developed Carcinomatous meningitis in breast cancer, Cochereau et al, found that patients had a median survival of 4 months after treatment with intrathecal methotrexate [7]. Similar results were found by Boogerd et al, who found a median survival of 18.3 weeks with intrathecal methotrexate and 30.3 weeks with non-intrathecal methotrexate [10].…”
Section: © 2023: Global Academic Journal's Research Consortium (Gajrc...supporting
confidence: 53%
See 1 more Smart Citation